Back
Calidi Biotherapeutics, Inc. Stock Predictions
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
24
CLDI
Calidi Biotherapeutics, Inc.
Last Price:
$1.36
Seasonality Move:
-32.48%
7 Day Trial
ALL ACCESS PASS
$
7
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCalidi Biotherapeutics, Inc. Stock Forecast
-
Is Calidi Biotherapeutics, Inc. Stock Undervalued?The current Calidi Biotherapeutics, Inc. [CLDI] share price is $1.36. The Score for CLDI is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
CLDI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Calidi Biotherapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Calidi Biotherapeutics, Inc. Stock Rating
Data Unavailable
Calidi Biotherapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
calidibio.com
52-Week Data
52-Week High:
19.20
52-Week Low:
1.10
Prediction Charts
Market Cap:
9.7M
Price in USD:
1.36
Volume:
69.8K
Beta:
2.66
Technical Analysis
SMA50:
1.49
SMA100:
2.11
SMA200:
4.06
52-Wk Change:
-92.18%
Stock Predictions
-
Is Calidi Biotherapeutics, Inc. stock public?Yes, Calidi Biotherapeutics, Inc. is a publicly traded company.
-
What is the Calidi Biotherapeutics, Inc. stock quote today?The Calidi Biotherapeutics, Inc. stock price is 1.36 USD today.
-
How to buy Calidi Biotherapeutics, Inc. stock online?You can buy Calidi Biotherapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 1.43 | 1.43 | 1.48 | 1.41 |
| Dec-3 | 1.43 | 1.50 | 1.50 | 1.38 |
| Dec-4 | 1.50 | 1.54 | 1.54 | 1.46 |
| Dec-5 | 1.52 | 1.46 | 1.55 | 1.42 |
| Dec-8 | 1.41 | 1.47 | 1.50 | 1.41 |
| Dec-9 | 1.47 | 1.52 | 1.52 | 1.45 |
| Dec-10 | 1.52 | 1.50 | 1.54 | 1.47 |
| Dec-11 | 1.45 | 1.47 | 1.50 | 1.44 |
| Dec-12 | 1.49 | 1.46 | 1.52 | 1.44 |
| Dec-15 | 1.50 | 1.33 | 1.50 | 1.32 |
| Dec-16 | 1.32 | 1.30 | 1.35 | 1.29 |
| Dec-17 | 1.31 | 1.25 | 1.33 | 1.25 |
| Dec-18 | 1.25 | 1.31 | 1.34 | 1.25 |
| Dec-19 | 1.28 | 1.36 | 1.38 | 1.28 |
Calidi Biotherapeutics, Inc. Earnings
Data Unavailable
Calidi Biotherapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.13 per share.
* Calidi Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.